Condition
Renal Transplant Rejection clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Renal Transplant Rejection clinical trials that are recruiting, at sites in 2 countries (most in United States (1), France (1)). By phase: Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Induction in sensitized kidney transplant recipients without pre-existing donor-specific antibodies
This trial tests whether basiliximab or rabbit anti-thymocyte globulin (rATG) work better as induction therapy for adults awaiting kidney transplant who have anti-HLA antibodies but no donor-specific antibodies.
-
Combined kidney and blood stem cell transplant from a sibling donor
This study is testing a new treatment for kidney transplant recipients to see if using a sibling's blood stem cells can help them accept their new kidney without needing lifelong medications to prevent rejection.
Related topics
Quick answers
How many Renal Transplant Rejection clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.